CLINICAL_TRIALS
trial_result
· 2026-07-31
Clinical Trial Results: Phase 1/2 Dose Confirmation Study of FLT180a in Hemophilia B [Phase 1, Phase 2]
Summary
Phase 1/2 dose-confirmation study of FLT180a in Hemophilia B was terminated; results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Spur Therapeutics | Conditions: Hemophilia B | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-07-31